Project Grant HT94252510917
Award Date 10/1/25
Completion Date 9/30/27
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
- The Feinstein Institutes for Medical Research was awarded a $999,972.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective from July 1, 2025 to June 30, 2029, is for a project titled "Studying Urine Macrophages in Lupus Nephritis to Shed Light on Kidney Disease Processes". As a non-profit medical research organization, the Feinstein Institutes will conduct advanced biomedical research to transform...
- The Feinstein Institutes for Medical Research was awarded a $655,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research characterizing immunological and genomic resistance mechanisms to anti-PD-1 immunotherapy in smoking-associated head and neck cancer. The grant period runs from April 15, 2022 to April 14, 2025. Through this funding, the Feinstein Institutes will investigate...
- The Feinstein Institutes for Medical Research was awarded a $749,998 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support modeling of human lymph node heterogeneity in mouse models. Through this funding, the Feinstein Institutes will conduct research services aimed at transforming health care for service members and the public by investigating medical solutions applicable to battlefield...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $299,937.00 to The Feinstein Institutes For Medical Research to conduct research on visualizing neural synaptic density in systemic lupus erythematosus (SLE) to better understand mechanisms of brain dysfunction. The award period runs from July 15, 2024 to July 14, 2026. The Feinstein Institutes, a non-profit research organization, will utilize this...
- The federal Project Grant award of $837,500.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research on "OXYGEN CONSERVING REFLEX: A NOVEL MULTIMECHANISTIC THERAPEUTIC INTERVENTION FOR TBI." The research will investigate an innovative approach to address traumatic brain injury (TBI) by examining a novel oxygen conserving reflex. The award will support this...
- The Defense Health Agency awarded a $202,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai. The award, with a period of performance from September 30, 2025 to September 29, 2026, will support advanced biomedical research focused on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis" at the institution's facilities in New York, NY. The Military Medical Research and...
- The Defense Health Agency awarded a $487,407 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Factor Bioscience Inc. in East Cambridge, MA. The grant supports the development of iPSC-derived mesenchymal stromal cells expressing a novel TNF inhibitor for the treatment of rheumatoid arthritis. The award period is from August 1, 2025 to July 31, 2026. The Military Medical Research and Development program funds advanced biomedical research to transform...
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
- The U.S. Department of Defense's Defense Health Agency awarded a $2,175,896 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research focuses on investigating metabolites, metabolic pathways, and their relationship to the risk...
- The U.S. Department of Defense's Defense Health Agency has awarded a $5,099,737 Project Grant to 149 Bio LLC in Miami, FL under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, which runs from July 1, 2025 through June 30, 2029, is for the development of a novel myeloid-targeted therapeutic for the treatment of glomerular diseases. This aligns with the program's focus on advanced biomedical research to transform healthcare for military service...